---
title: "recent"
date: "2024-09-25"
enableToc: true
---

> get back to [[index]]
# 最近編輯的檔案

## 更久以前

- 2024-09-12 11:13 [[recent]]
- 2024-09-11 11:28 [[asco_2024]]
- 2024-09-10 15:58 [[asco]]
- 2024-09-10 15:58 [[tnt]]
- 2024-09-10 12:01 [[rectal cancer]]
- 2024-09-10 12:00 [[colorectal cancer]]
- 2024-09-10 12:00 [[gastrointestinal malignancies]]
- 2024-09-06 17:18 [[opd_note_in_oncology]]
- 2024-09-05 17:55 [[clinical_immuno-oncology]]
- 2024-09-05 17:54 [[development_and_structure_of_the_lymphoid_system]]
- 2024-09-05 17:54 [[schematic_of_structure_and_lec_heterogeneity_of_lymph_node]]
- 2024-09-05 17:51 [[immunotherapy and cellular therapy]]
- 2024-09-05 17:51 [[oncology]]
- 2024-09-05 16:59 [[management_refractory_recurrent_and_metastatic_disease_of_anal_cancer]]
- 2024-09-05 16:55 [[apr]]
- 2024-09-05 16:31 [[anal cancer]]
- 2024-09-05 16:31 [[epidemiology_of_anal_cancer]]
- 2024-09-05 16:31 [[clinical_manifestations_of_anal_cancer]]
- 2024-09-05 16:31 [[workup_and_staging_of_anal_cancer]]
- 2024-09-05 16:31 [[pathology_and_molecular_biology_of_anal_cancer]]
- 2024-09-05 16:31 [[management_nonmetastatic_disease_of_anal_cancer]]
- 2024-09-05 16:31 [[management_of_perianal_cancer]]
- 2024-09-05 16:26 [[nigro_protocol]]
- 2024-09-05 16:21 [[pretreatment_considerations_of_nigro_protocol]]
- 2024-09-05 16:21 [[role_of_mitomycin]]
- 2024-09-05 16:21 [[mitomycin]]
- 2024-09-05 15:20 [[zen_of_oncology]]
- 2024-09-05 15:18 [[general oncology]]
- 2024-09-05 15:18 [[met_sites_of_clinical_manifestations_of_anal_cancer]]
- 2024-09-05 11:59 [[cancer_protocols]]
- 2024-09-05 11:59 [[abvd]]
- 2024-09-05 11:59 [[xelox]]
- 2024-09-05 11:59 [[Rituximab]]
- 2024-09-05 11:59 [[anti-CD20]]
- 2024-09-05 11:59 [[anti-CD20 2]]
- 2024-09-05 11:59 [[pc]]
- 2024-09-05 11:59 [[pec]]
- 2024-09-05 11:59 [[Pemetrexed]]
- 2024-09-05 11:58 [[pcb]]
- 2024-09-05 11:58 [[nab-paclitaxel-gemcitabine]]
- 2024-09-05 11:58 [[MVAC]]
- 2024-09-05 11:58 [[mFOLFOX6]]
- 2024-09-05 11:58 [[Modified FOLFOX6 chemotherapy for gastrointestinal cancer]]
- 2024-09-05 11:58 [[hdfl]]
- 2024-09-05 11:58 [[hd]]
- 2024-09-05 11:58 [[Trastuzumab]]
- 2024-09-05 11:58 [[cancer pharmacology]]
- 2024-09-05 11:58 [[gp]]
- 2024-09-05 11:58 [[gc-bladder_cancer]]
- 2024-09-05 11:58 [[folfox4]]
- 2024-09-05 11:58 [[FOLFIRI]]
- 2024-09-05 11:58 [[fluorouracil_leucovorin]]
- 2024-09-05 11:58 [[ep]]
- 2024-09-05 11:58 [[docetaxel_weekly]]
- 2024-09-05 11:58 [[docetaxel_q3w]]
- 2024-09-05 11:58 [[dc-lung_cancer]]
- 2024-09-05 11:58 [[dc-breast_cancer]]
- 2024-09-05 11:58 [[cop]]
- 2024-09-05 11:58 [[CMF]]
- 2024-09-05 11:57 [[chop]]
- 2024-09-05 11:57 [[cetuximab_folfox4]]
- 2024-09-05 11:57 [[cetuximab_folfiri]]
- 2024-09-05 11:57 [[pf]]
- 2024-09-05 11:57 [[bevacizumab_mfolfox6]]
- 2024-09-05 11:57 [[bevacizumab_folfiri]]
- 2024-09-05 11:56 [[Bendamustine]]
- 2024-09-05 11:56 [[atc]]
- 2024-09-05 11:56 [[ap_doxorubicin_cisplaitn]]
- 2024-09-05 11:56 [[AP]]
- 2024-09-05 11:56 [[a-cmf]]
- 2024-09-05 11:56 [[ac_docetaxel]]
- 2024-09-05 11:56 [[ac_paclitaxel]]
- 2024-09-05 11:55 [[化療一般注意事項]]